PlGF Gene Therapy Improves Heart Repair After Heart Attack
Author Information
Author(s): Iwasaki Hiroto, Kawamoto Atsuhiko, Tjwa Marc, Horii Miki, Hayashi Saeko, Oyamada Akira, Matsumoto Tomoyuki, Suehiro Shigefumi, Carmeliet Peter, Asahara Takayuki
Primary Institution: Stem Cell Translational Research, Institute of Biomedical Research and Innovation/RIKEN Center for Developmental Biology, Kobe, Japan
Hypothesis
Can placental growth factor (PlGF) gene therapy enhance cardiac repair and regeneration after myocardial infarction?
Conclusion
PlGF gene therapy significantly improves cardiac performance and reduces infarct size after myocardial infarction by promoting angiogenesis and protecting cardiomyocytes.
Supporting Evidence
- PlGF gene therapy improved cardiac performance after myocardial infarction.
- PlGF reduced the size of the heart infarct by promoting cell survival.
- PlGF increased the recruitment of bone marrow-derived progenitor cells to the heart.
Takeaway
This study shows that a special protein called PlGF can help heal the heart after a heart attack by making new blood vessels and keeping heart cells alive.
Methodology
The study used myocardial PlGF gene therapy in rat models of myocardial infarction, assessing cardiac function through echocardiography and histological analysis.
Potential Biases
Potential bias in the selection of animal models and the interpretation of results.
Limitations
The study was conducted in animal models, which may not fully replicate human responses.
Participant Demographics
Male Sprague-Dawley rats and C57BL/6 mice aged 6 to 9 weeks.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website